258 related articles for article (PubMed ID: 24124553)
1. Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.
Li YQ; Liu FF; Zhang XM; Guo XJ; Ren MJ; Fu L
PLoS One; 2013; 8(10):e76379. PubMed ID: 24124553
[TBL] [Abstract][Full Text] [Related]
2. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L
Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105
[TBL] [Abstract][Full Text] [Related]
3. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs.
Demir L; Yigit S; Ellidokuz H; Erten C; Somali I; Kucukzeybek Y; Alacacioglu A; Cokmert S; Can A; Akyol M; Dirican A; Bayoglu V; Sari AA; Tarhan MO
Clin Exp Metastasis; 2013 Dec; 30(8):1047-62. PubMed ID: 23836289
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
5. FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.
Freier CP; Kuhn C; Endres S; Mayr D; Friese K; Jeschke U; Anz D
Anticancer Res; 2016 Jun; 36(6):3139-45. PubMed ID: 27272839
[TBL] [Abstract][Full Text] [Related]
6. CCL1 is a major regulatory T cell attracting factor in human breast cancer.
Kuehnemuth B; Piseddu I; Wiedemann GM; Lauseker M; Kuhn C; Hofmann S; Schmoeckel E; Endres S; Mayr D; Jeschke U; Anz D
BMC Cancer; 2018 Dec; 18(1):1278. PubMed ID: 30572845
[TBL] [Abstract][Full Text] [Related]
7. Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients.
Liu F; Li Y; Ren M; Zhang X; Guo X; Lang R; Gu F; Fu L
Breast Cancer Res Treat; 2012 Sep; 135(2):459-67. PubMed ID: 22842982
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
Gupta S; Joshi K; Wig JD; Arora SK
Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between TGF- β1 expression and Treg cell infiltration in glioma].
Zhang GH; Jiang XB; Zhang XH; Sai K; Yang QY; Chen ZP; Mou YG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):680-2. PubMed ID: 21882476
[TBL] [Abstract][Full Text] [Related]
11. Nodal status in luminal A invasive breast cancer: relationships with cytotoxic CD8 + and regulatory FOXP3 + cells tumor-associated infiltrate and other prognostic factors.
Glajcar A; Łazarczyk A; Tyrak KE; Hodorowicz-Zaniewska D; Streb J; Okoń K; Szpor J
Virchows Arch; 2021 Nov; 479(5):871-882. PubMed ID: 34117905
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.
Gobert M; Treilleux I; Bendriss-Vermare N; Bachelot T; Goddard-Leon S; Arfi V; Biota C; Doffin AC; Durand I; Olive D; Perez S; Pasqual N; Faure C; Ray-Coquard I; Puisieux A; Caux C; Blay JY; Ménétrier-Caux C
Cancer Res; 2009 Mar; 69(5):2000-9. PubMed ID: 19244125
[TBL] [Abstract][Full Text] [Related]
13. A Standardized Evaluation Method for FOXP3+ Tregs and CD8+ T-cells in Breast Carcinoma: Association With Breast Carcinoma Subtypes, Stage and Prognosis.
Papaioannou E; Sakellakis M; Melachrinou M; Tzoracoleftherakis E; Kalofonos H; Kourea E
Anticancer Res; 2019 Mar; 39(3):1217-1232. PubMed ID: 30842152
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells are an important prognostic factor in breast cancer: a systematic review and meta-analysis.
Wang Y; Sun J; Zheng R; Shao Q; Gao W; Song B; Chen X; Qu X
Neoplasma; 2016; 63(5):789-98. PubMed ID: 27468884
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
Li F; Zhao Y; Wei L; Li S; Liu J
Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
[TBL] [Abstract][Full Text] [Related]
16. FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
Lal A; Chan L; Devries S; Chin K; Scott GK; Benz CC; Chen YY; Waldman FM; Hwang ES
Breast Cancer Res Treat; 2013 Jun; 139(2):381-90. PubMed ID: 23712790
[TBL] [Abstract][Full Text] [Related]
17. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
18. Relationship and clinical significance of TGF-beta1 expression with Treg cell infiltration in hepatocellular carcinoma.
Lin GH; Wang J; Li SH; Wang J; Xu L; Li SP
Chin J Cancer; 2010 Apr; 29(4):403-7. PubMed ID: 20346216
[TBL] [Abstract][Full Text] [Related]
19. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
20. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype.
Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D
Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
